Gerald Joe K, Stroupe Nancy, McClure Leslie A, Wheeler Lani, Gerald Lynn B
Pediatr Allergy Immunol Pulmonol. 2012 Mar;25(1):11-16. doi: 10.1089/ped.2011.0118.
This paper documents individual asthma action plan presence and quick relief medication (albuterol) availability for elementary students enrolled in five Alabama school systems. PATIENTS AND METHODS: Data were obtained during baseline data collection (fall 2005) of a school-based supervised asthma medication trial. All students attended 1 of 36 participating elementary schools across five school systems in Jefferson County, Alabama. In addition, they had to have physician-diagnosed asthma requiring daily controller medication. Each school system had its own superintendent and elected school board. Asthma action plan presence and albuterol availability was confirmed by study personnel. Asthma action plans had to contain daily and acute asthma management instructions. Predictors of asthma action plan presence and albuterol availability were also investigated. Associations between albuterol availability and self-reported characteristics including health care utilization prior to study enrollment and outcomes during the study baseline period were also investigated. RESULTS: Enrolled students had a mean (SD) age of 11.0 (2.1) years, 91% were African American, and 79% had moderate persistent asthma. No student had a complete asthma action plan on file and only 14% had albuterol physically available at school. Albuterol availability was not predicted by gender, race, insurance status, second-hand smoke exposure, need for pre-exercise albuterol, asthma severity, or self-reported health care utilization prior to study enrollment. Albuterol availability did not predict school absences, red/yellow peak flow recordings, or medication adherence during the study's baseline period. CONCLUSION: Despite policies permitting students to possess albuterol, few elementary students across five independent school systems in Alabama actually had it readily available at school.
本文记录了阿拉巴马州五个学校系统中注册的小学生的个人哮喘行动计划情况以及速效缓解药物(沙丁胺醇)的可获得性。
数据来自一项基于学校的哮喘药物监督试验的基线数据收集阶段(2005年秋季)。所有学生就读于阿拉巴马州杰斐逊县五个学校系统中的36所参与小学中的一所。此外,他们必须有医生诊断的哮喘且需要每日使用控制药物。每个学校系统都有自己的学监和选举产生的学校董事会。研究人员确认了哮喘行动计划的存在情况和沙丁胺醇的可获得性。哮喘行动计划必须包含每日和急性哮喘管理指导。还调查了哮喘行动计划存在和沙丁胺醇可获得性的预测因素。还研究了沙丁胺醇可获得性与自我报告特征之间的关联,包括研究入学前的医疗保健利用情况和研究基线期的结果。
注册学生的平均(标准差)年龄为11.0(2.1)岁,91%为非裔美国人,79%患有中度持续性哮喘。没有学生有完整的哮喘行动计划存档,只有14%的学生在学校实际备有沙丁胺醇。沙丁胺醇的可获得性不受性别、种族、保险状况、二手烟暴露、运动前是否需要使用沙丁胺醇、哮喘严重程度或研究入学前自我报告的医疗保健利用情况的预测。在研究的基线期,沙丁胺醇的可获得性并不能预测学校缺勤、红/黄峰流速记录或药物依从性。
尽管有政策允许学生持有沙丁胺醇,但阿拉巴马州五个独立学校系统中的小学生实际上在学校能轻易获得该药的却很少。